Barbara Ryan - 09 Sep 2025 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
INKT
Transactions as of
09 Sep 2025
Transactions value $
$0
Form type
4
Filing time
11 Sep 2025, 16:05:03 UTC
Previous filing
03 Sep 2025
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ryan Barbara Director 149 FIFTH AVENUE, SUITE 500, NEW YORK By: /s/ Christine Klaskin, Attorney-in-Fact 11 Sep 2025 0001827169

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INKT Stock Option (Right to Buy) Award $0 +3,225 $0 3,225 09 Sep 2025 Common Stock 3,225 $15.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.